Stable Ventricular Fibrillation : A Paradigm Rather Than Septal Shift?
Copyright © ASAIO 2023..
Awake patients in ventricular fibrillation is a phenomenon limited to patients who are mechanically supported. We describe a cohort of patients supported by left ventricular assist devices (LVADs) presenting to the emergency department (ED) at a high-volume LVAD center while in awake ventricular fibrillation (VF)/ventricular tachycardia (VT). Among 175 patients reviewed, a total of 19 LVAD patients presented to the ED in awake VF/VT between December 2015 and July 2021. On ED presentation, patients maintained a median mean arterial blood pressure (MAP) of 70 mm Hg with a mean LVAD flow of 3.77 L/minute. ED management included cardioversion in the majority of cases: 58% were defibrillated once, 21% were defibrillated multiple times, 68% received amiodarone, and 21% received lidocaine. Inpatient management included defibrillation, ablation, and antiarrhythmic initiation in 37%, 11%, and 84% of cases, respectively. In total, five patients (26%) died with one death attributed to recurrent VT. Our findings support the short-term tolerability of sustained ventricular arrhythmias in LVAD patients, as evidenced by the maintained MAPs and mental status. Clinical teams, however, should be aware of the potential harbinger for in-hospital mortality heralded by an awake VF/VT presentation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:69 |
---|---|
Enthalten in: |
ASAIO journal (American Society for Artificial Internal Organs : 1992) - 69(2023), 9 vom: 01. Sept., Seite 835-840 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bracy, Connor L [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 01.09.2023 Date Revised 04.09.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1097/MAT.0000000000001984 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361489420 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM361489420 | ||
003 | DE-627 | ||
005 | 20231226085239.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/MAT.0000000000001984 |2 doi | |
028 | 5 | 2 | |a pubmed24n1204.xml |
035 | |a (DE-627)NLM361489420 | ||
035 | |a (NLM)37651097 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bracy, Connor L |e verfasserin |4 aut | |
245 | 1 | 0 | |a Stable Ventricular Fibrillation |b A Paradigm Rather Than Septal Shift? |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.09.2023 | ||
500 | |a Date Revised 04.09.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © ASAIO 2023. | ||
520 | |a Awake patients in ventricular fibrillation is a phenomenon limited to patients who are mechanically supported. We describe a cohort of patients supported by left ventricular assist devices (LVADs) presenting to the emergency department (ED) at a high-volume LVAD center while in awake ventricular fibrillation (VF)/ventricular tachycardia (VT). Among 175 patients reviewed, a total of 19 LVAD patients presented to the ED in awake VF/VT between December 2015 and July 2021. On ED presentation, patients maintained a median mean arterial blood pressure (MAP) of 70 mm Hg with a mean LVAD flow of 3.77 L/minute. ED management included cardioversion in the majority of cases: 58% were defibrillated once, 21% were defibrillated multiple times, 68% received amiodarone, and 21% received lidocaine. Inpatient management included defibrillation, ablation, and antiarrhythmic initiation in 37%, 11%, and 84% of cases, respectively. In total, five patients (26%) died with one death attributed to recurrent VT. Our findings support the short-term tolerability of sustained ventricular arrhythmias in LVAD patients, as evidenced by the maintained MAPs and mental status. Clinical teams, however, should be aware of the potential harbinger for in-hospital mortality heralded by an awake VF/VT presentation | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Amiodarone |2 NLM | |
650 | 7 | |a N3RQ532IUT |2 NLM | |
650 | 7 | |a Lidocaine |2 NLM | |
650 | 7 | |a 98PI200987 |2 NLM | |
700 | 1 | |a Kobres, Pei-Ying |e verfasserin |4 aut | |
700 | 1 | |a Hockstein, Michael J |e verfasserin |4 aut | |
700 | 1 | |a Rao, Sriram D |e verfasserin |4 aut | |
700 | 1 | |a Gupta, Richa |e verfasserin |4 aut | |
700 | 1 | |a Lam, Phillip H |e verfasserin |4 aut | |
700 | 1 | |a Sheikh, Farooq H |e verfasserin |4 aut | |
700 | 1 | |a Hockstein, Maxwell A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t ASAIO journal (American Society for Artificial Internal Organs : 1992) |d 1997 |g 69(2023), 9 vom: 01. Sept., Seite 835-840 |w (DE-627)NLM012606766 |x 1538-943X |7 nnns |
773 | 1 | 8 | |g volume:69 |g year:2023 |g number:9 |g day:01 |g month:09 |g pages:835-840 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/MAT.0000000000001984 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 69 |j 2023 |e 9 |b 01 |c 09 |h 835-840 |